LONG $ARDM (Aradigm) heading into 2 BIG Catalysts - HEADING UP ?
AARDM SHOULD BE HEADING UP INTO 2 BIG Catalysts - HEADING UP TO $8
1- ADCOM DAY ON JAN 11 2018
2- PDUFA date - priority review January 26, 2018. Phase 3 data released December 1, 2016.
Drug: Linhaliq (Pulmaquin) for Non-cystic fibrosis bronchiectasis (non-CF BE).
1- ADCOM DAY ON JAN 11 2018
2- PDUFA date - priority review January 26, 2018. Phase 3 data released December 1, 2016.
Drug: Linhaliq (Pulmaquin) for Non-cystic fibrosis bronchiectasis (non-CF BE).
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。